Abstract
Clarithromycin and clofazimine have been used to treat leprosy, tuberculosis and infections caused by the Mycobacterium avium complex. Since there is a scarcity of data on the toxicity of therapeutic regimens that include these drugs, this study had the aim of determining the adverse effects of these therapies, through evaluation of hematological, hemostatic and biochemical parameters. The drugs were administered to male Wistar rats, as monotherapy, in regimens of single and multiple doses. Clarithromycin caused increases in the numbers of mononuclear and polymorphonuclear leukocytes. Both of the drugs inverted the proportions between mononuclear and polymorphonuclear cells and increased the numbers of polymorphonuclear cells and degenerating cells. Clofazimine and clarithromycin prolonged the prothrombin time and clarithromycin also prolonged the activated partial thromboplastin time. Clarithromycin caused increases in total and direct bilirubin. Both of the drugs increased the plasma levels of gamma-glutamyltransferase. Therefore, clofazimine and clarithromycin induce hematological, hemostatic and hepatic changes.
References
Jun 1, 1979·Leprosy Review·S J Yawalkar, W Vischer
Feb 1, 1991·The Journal of Antimicrobial Chemotherapy·R Poirier
Feb 1, 1991·The Journal of Antimicrobial Chemotherapy·G H CassellJ C McIntosh
Mar 1, 1995·The Journal of Infectious Diseases·R J WallaceK Tanaka
Jul 1, 1993·The Journal of Infectious Diseases·B JiJ H Grosset
Jun 7, 1996·Journal of Chromatography. B, Biomedical Applications·R O'ConnorR O'Kennedy
Sep 11, 2002·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Regina Helena Costa QueirozEnzo Melchior
Nov 6, 1954·Nature·W N BELL, H G ALTON
Jul 1, 1957·American Journal of Clinical Pathology·S REITMAN, S FRANKEL
May 1, 1958·American Journal of Clinical Pathology·F H SIMS, C HORN
Oct 14, 2003·Chest·Stephen K Field, Robert L Cowie
Dec 18, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·K BazD Demirseren
Dec 14, 2005·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Claudio Petterino, Alberta Argentino-Storino